Posted in | News | Nanoelectronics

Synopsys’ 40nm DesignWare MIPI M-PHY IP Now Available for Mobile Devices

Synopsys, Inc. (Nasdaq: SNPS), a world leader in software and IP for semiconductor design, verification and manufacturing, today announced immediate availability of the DesignWare® MIPI M-PHY® IP for next-generation high-speed interfaces based on the newly ratified MIPI® Alliance M-PHY specification.

With this latest addition to the DesignWare MIPI IP portfolio, Synopsys is the first provider to offer a comprehensive solution of a controller and PHY IP for both the MIPI DigRF(SM) v3 (2.5G/3.0G) and v4 (4G) standards. Incorporating both standards in a mobile device brings the benefit of the faster 4G standards while preserving broad coverage by using 2.5G/3.0G as a fallback mode. The configurable MIPI DigRF V4 Master Controller and M-PHY hard macro are compliant to the MIPI Alliance specifications. Utilizing a single-vendor solution enables designers to lower the risk and cost of integrating these MIPI interfaces into baseband and application processor integrated circuits (ICs), speeding time-to-market of advanced semiconductor solutions for LTE and Mobile WiMAX.

The DesignWare MIPI M-PHY implements all required physical layer functionality defined in the MIPI DigRF v4 specification. The DesignWare MIPI M-PHY is designed to meet the stringent power consumption guidelines of the MIPI M-PHY specification, keeping the energy expenditure below 15pJ/bit for typical LTE applications. The integrated analog Phase Lock Loop (PLL) and biasing block are designed to help guarantee the integrity of the high-speed clocks and signals required to meet the strict timing requirements of the protocol, affording designers a robust and low risk solution. In addition, the DesignWare MIPI M-PHY supports the optional dithering functionality defined in the MIPI DigRF v4 specification to further lower Electromagnetic Interference (EMI).

"As an active contributor to the MIPI working groups, Synopsys continues to make solid contributions that support the MIPI Alliance portfolio of specifications," said Joel Huloux, chairman of the MIPI Alliance. "Synopsys is speeding the adoption of the new M-PHY interface into mobile devices and helping designers benefit from the latest functionality offered by the MIPI-based technology."

"To address the growing usage of multimedia content in mobile devices, designers are using standards-based interfaces from the MIPI Alliance to help them meet the increased data throughput requirements for mobile terminals targeting 4G standard air interfaces," said John Koeter, vice president of marketing for the Solutions Group at Synopsys. "Synopsys is playing a key role in supporting the MIPI ecosystem by providing designers with high-quality DesignWare MIPI IP consisting of DigRF v3/v4, CSI-2, D-PHY, and M-PHY IP, enabling them to lower the risk of integrating MIPI interfaces into their designs."

Source: http://www.synopsys.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Synopsys, Inc.. (2019, February 13). Synopsys’ 40nm DesignWare MIPI M-PHY IP Now Available for Mobile Devices. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=19195.

  • MLA

    Synopsys, Inc.. "Synopsys’ 40nm DesignWare MIPI M-PHY IP Now Available for Mobile Devices". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=19195>.

  • Chicago

    Synopsys, Inc.. "Synopsys’ 40nm DesignWare MIPI M-PHY IP Now Available for Mobile Devices". AZoNano. https://www.azonano.com/news.aspx?newsID=19195. (accessed November 21, 2024).

  • Harvard

    Synopsys, Inc.. 2019. Synopsys’ 40nm DesignWare MIPI M-PHY IP Now Available for Mobile Devices. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=19195.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.